SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000945621-16-000649
Filing Date
2016-07-05
Accepted
2016-07-05 17:09:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D hudsoneagleamendmentno1.htm SC 13D/A 84790
  Complete submission text file 0000945621-16-000649.txt   86399
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88022 | Film No.: 161751416
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1185 AVENUE OF THE AMERICAS, 32ND FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 32ND FLOOR NEW YORK NY 10036 (212) 521-8495
Hudson Executive Capital LP (Filed by) CIK: 0001652522 (see all company filings)

IRS No.: 472878186 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A